A team led by researchers from Memorial Sloan Kettering Cancer Center has uncovered a novel mechanism by which fasting may aid in the fight against cancer. Their study, conducted in mice and published in Immunity, reveals that periods of fasting can reprogram the metabolism of natural killer (NK) cells, enhancing their ability to combat tumors.
"Tumors are very hungry," explained senior author Joseph Sun. "They take up essential nutrients, creating a hostile environment often rich in lipids that are detrimental to most immune cells. What we show here is that fasting reprograms these natural killer cells to better survive in this suppressive environment."
NK cells are a type of white blood cell that can identify and destroy abnormal or cancerous cells without prior exposure. The study found that when mice with cancer underwent intermittent fasting, their NK cells underwent metabolic changes that allowed them to thrive in the nutrient-deprived tumor microenvironment
Search Antibodies Search Now Use our Antibody Search Tool to find the right antibody for your research. Filter
by Type, Application, Reactivity, Host, Clonality, Conjugate/Tag, and Isotype.
During fasting cycles, the mice's NK cells learned to use fatty acids as an alternative fuel source to glucose. "This really optimizes their anti-cancer response because the tumor microenvironment contains a high concentration of lipids, and now they're able enter the tumor and survive better because of this metabolic training," said lead author Rebecca Delconte.
Additionally, fasting led to a redistribution of NK cells within the body. Many NK cells migrated to the bone marrow, where they were primed to produce more Interferon-gamma, a cytokine crucial for anti-tumor responses. Meanwhile, NK cells in the spleen underwent reprogramming to better utilize lipids as fuel.
"With both of these mechanisms put together, we find that NK cells are pre-primed to produce more cytokines within the tumor," Delconte explained. "And with the metabolic reprogramming, they're more able to survive in the tumor environment, and specialized to have improved anti-cancer properties.”
While further research is needed, the findings suggest that fasting could be a strategy to enhance the effectiveness of cancer immunotherapies by optimizing the body's natural defenses. However, caution is advised, as different types of fasting may have varying effects, and patients should consult their doctors before making any dietary changes.